Significantly greater expression of ER, PR, and ECAD in advanced-stage low-grade ovarian serous carcinoma as revealed by immunohistochemical analysis.

Source:http://linkedlifedata.com/resource/pubmed/id/17885490

Download in:

View as

General Info

PMID
17885490